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Abstract
Background: Community acquired Bacterial Meningitis (BM) remains a serious threat to global health. Cuban 
surveillance system for BM allowed to characterize the main epidemiological features of this group of diseases, as well 
as to assess the association of some variables with mortality. Results of the BM surveillance in Cuba are presented in 
this paper.
Methods: A follow up of BM cases reported to the Institute "Pedro Kourí" by the National Bacterial Meningitis 
Surveillance System from 1998 to 2007 was completed. Incidence and case-fatality rate (CFR) were calculated. 
Univariate analysis and logistic regression were used to elucidate associated factors to mortality comparing death 
versus survival. Relative Risk (RR) or odds ratio and its 95% confidence interval (CI 95%) were estimated, using either a 
Chi-squared Test or Fisher's Exact Test as appropriate. A Holt-Winters model was used to assess seasonality.
Results: 4 798 cases of BM (4.3 per 100 000 population) were reported, with a decreasing trend of the incidence. 
Highest incidence was observed in infants and elderly. Overall CFR reached 24.1% affecting mostly older adults. S. 
pneumoniae (23.6%), N. meningitidis(8.2%) and H. influenzaetype b (6.0%) were the main causative agents. Males 
predominate in the incidence. Highest incidence and CFR were mainly clustered in the centre of the island. The 
univariate analysis did not show association between delayed medical consultation (RR = 1.20; CI = 1.07-1.35) or 
delayed hospitalization (RR = 0.98; CI = 0.87-1.11) and the fatal outcome. Logistic regression model showed association 
of categories housewife, pensioned, imprisoned, unemployed, S. peumoniae and other bacteria with mortality. 
Seasonality during September, January and March was observed.
Conclusions: The results of the National Program for Control and Prevention of the Neurological Infectious Syndrome 
evidenced a reduction of the BM incidence, but not the CFR. Multivariate analysis identified an association of mortality 
with some societal groups as well as with S. peumoniae.
Background
Despite the advances in antibiotic therapy and vaccines as
well as the availability of sophisticated intensive care
reached in the past century and the ongoing, community
acquired Bacterial Meningitis (BM) remains a serious
threat to global health [1,2].
Several issues support its relevance. BM is a leading
cause of high morbidity in all ages but young children are
at great risk, especially infants. This often fatal disease
accounts for an estimated annual 170 000 deaths world-
wide and case fatality rates (CFR) remain at 5-10% in
industrialized countries, and are even higher in the devel-
oping world [1,3-6]. Between 10-20% of survivors develop
permanent sequel such as epilepsy, mental retardation or
deafness and other neurological disabilities which may
contribute to the Global Burden of BM measured as the
disability adjusted life years (DALYs) [7].
A great variety of bacteria can cause BM although three
species, Streptococcus pneumoniae), Neisseria meningiti-
dis and  Haemophilus influenzae type b (Hib) are respon-
sible for most cases of bacterial meningitis occurring
beyond the neonatal period, causing more than 80% of
cases worldwide [1]. On the other hand a decrease of the
susceptibility to conventional and new antibiotics may
difficult the treatment [3]. Fortunately there are vaccines
against the most common aetiological agents, with high
efficacy [1-3], but their use and coverage are unequal
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depending on public health and economical resources in
each country.
Surveillance remains an essential tool to identify the
cases, the aetiological agents, and other important epide-
miological variables. Routine surveillance systems differ
according to the different regions. In the developed world
they are mostly based on mandatory notifications of
infectious diseases and more recently on laboratory [8-
11], while in developing countries are based on case
reports and epidemics notifications [12], as well as on
hospital sentinel surveillance [13].
First cases of cerebrospinal meningitis in Cuba were
reported in 1916. Since 1961 a Mandatory Report of Dis-
eases, including BM, was implemented by Public Health
Ministry. Later in 1979 and during an invasive meningo-
coccal disease epidemic, due to serotypes B and C, a spe-
cial nationwide surveillance known as Direct Information
System arose with the interest to achieve a completeness
and timeliness in reporting cases [14,15]. In 1983 it was
added an automated questionnaire for reporting. After-
wards, in 1998, all causative bacteria were put under sur-
veillance through an updated questionnaire including
complementary information about confirmed cases and
different of those routinely collected, remaining as the
national data source for the National Program for Control
and Prevention of the Neurological Infectious Syndrome
(NPCPNIS) [16].
The aim of this paper was to characterize the main epi-
demiological features of BM in Cuba during a ten year
period, as well as to assess the association with mortality
of some variables reported by surveillance.
Methods
Surveillance for Bacterial Meningitis
We included in the study 4798 confirmed cases of BM
reported to the Institute "Pedro Kourí" (IPK) by the
National Bacterial Meningitis Surveillance System
(BMSS) from January 1, 1998 to December 31, 2007,
including all causative bacteria and considering the date
of the symptoms onset.
The case definition was "a clinical meningeal syndrome,
through the identification of the causal agent directly by
culture blood, petecchias, cerebrospinal fluid (CSF) anal-
ysis or indirectly by polymerase chain reaction, latex test
or another rapid diagnostic test. The cases with negative
culture or bacteriological test, but the cyto-chemical
exam of the CSF suggested bacterial infection, were con-
sidered BM of "unknown aetiology" [17]. Reported cases
due to N. meningitidis included both, meningitis and sep-
ticaemia. Standardized case-report form including infor-
mation on demographic, clinical presentation, symptoms
onset, first medical consultation, hospital admittance and
decease date, some occupational-related categories
(housewife, student, boarding student, pensioned,
imprisoned, military, children attending day care centres,
children at home, recluse, unemployed, worker) and
other epidemiological data, was completed for each case
by provincial epidemiologists.
The present study did not require approval from an
Ethics Committee. The Cuban Ministry of Public Health
is the governmental organization responsible for the col-
lection of infectious disease notifications, hospital dis-
charge records and population or laboratory surveillance.
The management of these data for public health purposes
does not require a patient's informed consent nor does it
require any authorization regarding privacy laws in Cuba.
Statistical analysis
Cuban population estimates based on the national census
for the years 1998 through 2007 were obtained from the
Office for National Statistics in Cuba. A tendency to
homogenization is among the main demographic charac-
teristics of Cuban population, especially in the last four
decades; therefore the age composition of population
groups is very similar in all the regions. On the other
hand, in Cuban population there are no racial, indige-
nous, religious or other social groups different to the
main population.
Incidence per/100 000 population and case-fatality rate
(CFR) per/100 cases were calculated according to the
age-group, gender and provinces.
Age group selection in children and adolescents 1-19
year olds was made on the basis of the attendance to main
educational levels: 1-5 years olds attend Day Care Centres
(DCC), those 6-11 year olds attend Primary Schools, 12-
14 year olds go to Secondary Basic Schools and those 15-
19 year olds attend mostly Pre-university, other Technical
and Professional Schools. Population older than 20 years
was distributed by quinquennial age groups.
The time series analysis was done by the best adjusted
method (linear trend), choosing the minimum mean
square error and minimum interval residuals as appropri-
ate test for trend assumption.
A Holt-Winters multiplicative analysis was used to
analyse the seasonality by using the monthly reported
cases.
Univariate analysis was used to elucidate associated
factors to mortality comparing deaths versus survival. For
the assessment of the timeliness of the medical attention
and hospitalization we defined delayed medical consulta-
tion as "the time elapsed between the symptoms onset
and the first medical consultation greater than one day"
and delayed hospitalization as "the time elapsed between
the first medical consultation and hospitalization greater
than one day".
Also it was assessed by univariate analysis the associa-
tion of fatal outcome with some host factors (male, chil-
dren attending DCC, children at home, student, boardingPérez et al. BMC Infectious Diseases 2010, 10:130
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student, housewife, pensioned, military, imprisoned,
worker, unemployed, S. pneumoniae, H. influenzae type
b, N. meningitidis, other identified bacteria and non-iden-
tified agent). Association was estimated through Relative
Risk (RR) and its 95% confidence interval (CI 95%). Age
was excluded because it was not possible to rise solid
hypothesis allowing dichotomising the rank associated to
death, but in regression analysis exact age was included.
Additionally, it was carried out a multiple logistic
regression analysis to variables with RR>1. The model
was fitted including the selected variables and subse-
quently dropped one by one until only those that were
associated (OR>1.6). We used Epi Info 2002 database,
NCSS 2000-PASS 2000 statistic software and Excel (ver-
sion 5.1) for the statistical analysis, and Microsoft Office
Word 2003 (11.5604.5606) as the text processor program.
Results
Morbidity
During the study period a total of 4798 cases of BM was
reported for an annual average of 480 patients and inci-
dence of 4.3/100 000 population. Comparison of the
annual incidence in 1998 (5.5/100 000 population) with
2007 (3.1/100 000 population), showed a significant
decrease (43.6%, p < 0.01) and therefore, a decreasing
trend (y = -0.2957x + 5.8867; Mean Square Error = 0.2767
and -1 to 1 as residuals interval), with an incidence fore-
cast of 2.6 and 2.3 for the next couple years (Data not
shown).
All age groups decreased the incidence with the excep-
tion of 12-14 and 45-49 years old, which contrarily
increased slightly the incidence 5.3% and 26.1% respec-
tively. The highest incidence reductions of the period
were observed in older than 84 group (74.0%), 65-74 year
olds (65.3%), 1-5 year olds (60.0%) and infants (58.9%)
(Table 1).
With the exception of children under 11 year olds and
adults above 74 year olds, all age groups showed an inci-
dence equal or below 6/100 000 population. The highest
annual average incidence by age group was observed in
infants and children less than 6 years old. The elderly also
showed high incidence rates, especially the older than 74
years. The age group with lower rate was 30-34 year olds
with 1.7/100 000 population. In the majority of the age
groups annual incidence varied considerably along the
period (Figure 1).
One thousand four hundred twenty nine cases (39.8%)
were younger than 6 years, of them 737 under 1 year old
(15.4%) and 692 were aged 1-5 years old (14.4%). These
were the most numerous age groups of all. In infants the
mean age was 5.3 months, the median 5 months and the
mode 2 months (Data not shown).
Mortality
For the 1998-2007 period a total of 1157 fatal cases were
reported and the overall CFR reached 24.1%. Annually
variations were observed, with the highest numbers in
2002 (28.5%) and the lowest in 2007 (19.7%) (Table 2).
Overall CFR by age groups showed figures over 30% in
those above 49 year olds, especially 65-74 (53.0%), 75-84
year olds (64.3%) and the older than 84 years group
(67.0%). Among those aged below 15 years the highest
CFR were observed mainly in infants (17.0%) (Figure 1).
Main causative pathogens
Distribution of BM causative agents was as follows: BM
of unknown aetiology 2654 (55.3%), S. pneumoniae 1131
(23.6%), N. meningitidis 395 (8.2%), Hib 286 (6.0%) and
other identified bacteria 332 (6.9%). Three hundred
ninety five cases of Invasive Meningococcal Disease were
separated in 304 meningitis (77.0%), 85 septicaemia
(21.5%) and 6 (1.5%) both, meningitis and septicaemia.
Major other identified bacteria were Staphylococcus ssp.,
Streptococcus ssp.,  E. coli and  Klebsiella ssp. (Data not
shown).
Gender
Gender analysis of the overall and annually male inci-
dence (5.0 per 100 000 population) showed a significant
predominance over female (3.6 per 100 000 population).
Contrarily, in overall CFR, female (26.4%) predominate
slightly over male (22.4%) as also occurred annually, with
the exceptions of years 2003 and 2004 when male CFR
exceeded female (Data not shown).
Geographical analysis
Geographical distribution of the average incidence
showed that three of the five provinces with higher inci-
dence were clustered in the centre of the island (Villa
Clara 5.1 per 100 000 population, Cienfuegos 5.7 per 100
000 population and SS 7.2 per 100 000 population). The
Capital City, Ciudad de La Habana (5.0 per 100 000 popu-
lation) in the western region and Guantánamo in the
eastern (5.9 per 100 000 population) also showed high
incidence (Figure 2).
Also the higher cumulative CFR was clustered in the
central provinces of the island, but towards the eastern
side (Cienfuegos 28.8%, Sancti Spiritus 25.4%, Ciego de
Avila 32.5% and Camagüey 26.2%). Also Ciudad de La
Habana in the western side (27.1%) and Guantánamo
(28.9%) in the eastern region showed high CFR (Data not
shown).
Risks
In our study it was possible to obtain the information
about the time elapsed between symptoms onset and first
medical consultation in 4100 reported cases (85.5%). Of
those with available information, a total of 1 139 casesPérez et al. BMC Infectious Diseases 2010, 10:130
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were consulted with delay (27.8%) and 2 961 cases were
consulted timely (82.2%). The univariate analysis showed
a poor association (RR = 1.20; CI = 1.07-1.35) between
delayed medical consultation and death. According to
report, 1103 cases were hospitalized with delay (54.1%)
and 936 cases (45.9%) were hospitalized timely, but nei-
ther an association was found (RR = 0.98; CI = 0.87-1.11)
(Table 3).
Univariate analysis for societal categories only showed
association with housewife (OR = 1.98; CI 95% 1.79-2.20),
pensioned (OR = 2.65; CI 95% 2.40-2.92), unemployed
(OR = 1.68; CI 95% 1.40-2.01), S. pneumoniae (OR = 1.62;
CI 95% 1.46-1.80), other bacteria (OR = 1.39; CI 95%
1.18-1.64) (Data not shown).
Logistic regression model only showed association
(OR>1.6) of the fatal outcome with housewife, pensioned,
imprisoned, unemployed, S. peumoniae and other bacte-
ria (Table 4).
Monthly distribution
Cumulative monthly mean of cases evidenced three
major peak in January (39 cases), March (37 cases) and
September (39). The higher number was observed in Jan-
uary and September and the lower number in December
(23) (Figure 3). Holt-Winters multiplicative model
showed the main increases above monthly mean inci-
dence of the period in September (19%), January (15%)
and March (12%), confirming the general seasonality on
BM.
Discussion
Likewise those of developed countries [9-11], BMSS has
been useful and proficient providing and synthesizing
critical and multidisciplinary information [16,17] for
more than a decade, fulfilling all suitable surveillance sys-
tem attributes [17,18]. Changes implemented in 1998
allowed collecting data which contributed to assess main
objectives of both, the National Immunisation Program
(NIP) and the NPCPNIS.
However, very few cases of BM might have been missed
or misdiagnosed despite the strict control of surveillance
and reporting. On the other hand, possible information
bias from patients and their relatives was reduced after
successive interviews by epidemiologists at hospital and
home, as a part of the hot bed control.
Infants and elderly are the most affected age groups by
BM and the overall incidence in the study was low and
comparable with those of the developed world.
Declining of BM incidence may be the result of the
rational use of preventive and control measures nation-
wide. The impact of vaccination against N. meningitidis
serotype B and C carried out in 1989 (vaccination cam-
paign targeted to population under 20 years with nearly
95% coverage) and continued in 1991 by the NIP (VA-
Table 1: Annual incidence of bacterial meningitis, Cuba, 1998-2007
Age 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007
< 1 81.2 66.7 84.1 56.5 40.5 47.8 43.5 51.2 34.5 33.4
1-5 19.0 16.0 11.1 8.8 4.8 6.4 7.4 9.3 5.8 7.6
6-11 5.0 7.9 4.1 3.6 3.4 5.0 2.9 5.7 3.1 4.0
12-14 2.2 5.9 3.7 3.6 4.3 4.2 2.8 2.2 3.3 3.4
15-19 3.7 4.5 4.5 3.0 1.8 1.9 2.7 4.3 3.0 2.5
20-24 2.8 2.5 1.7 3.9 2.2 1.9 2.0 3.3 1.4 1.5
25-29 2.1 2.7 3.0 1.8 1.2 2.2 2.0 3.5 1.5 1.4
30-34 1.8 2.2 2.7 0.9 1.4 1.0 2.2 2.2 1.8 1.4
35-39 2.4 2.1 2.5 1.4 1.9 2.5 1.5 2.8 1.7 2.2
40-44 2.4 2.8 2.8 1.4 2.7 2.7 3.7 2.0 0.8 1.3
45-49 1.7 3.0 2.2 3.4 3.1 3.2 1.8 2.8 2.2 2.3
50-54 3.2 4.2 3.8 3.6 4.0 3.0 3.9 3.6 3.9 2.6
55-59 5.6 5.0 4.6 5.0 3.4 2.8 2.9 4.1 2.3 3.0
60-64 3.3 6.8 6.0 4.7 3.4 3.7 4.3 5.5 2.3 3.0
65-74 7.5 7.7 7.3 6.5 5.0 4.1 4.4 4.8 3.3 2.6
75-84 9.0 10.7 7.2 10.5 7.3 6.6 5.2 5.7 6.4 6.9
> 84 7.7 9.0 13.4 13.1 9.3 3.6 4.2 6.1 9.6 2.0
Total 5.5 6.0 5.3 4.4 3.5 3.7 3.6 4.5 3.0 3.1Pérez et al. BMC Infectious Diseases 2010, 10:130
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MENGOC BC®, two dose schedule at 3 and 5 months of
age), as well as the successful vaccination against Hib car-
ried out in 1999 in children (three dose schedule at 2, 4, 6
months and a booster dose at 18 months) has been
reported [19,20]. Therefore, continuous vaccination and
high coverage (>95%) achieved in population under 11
years old (Hib) and under 40 years old (N. meningitidis)
along this period, may explain not only the decreasing
trend of the incidence in targeted population, but the
decrease in other age groups (herd immunity) [19,20]. At
present, S. pneumoniae remains the only major causative
bacteria of BM in Cuba without specific vaccination con-
trol; however the incidence was low and comparable with
those achieved by countries that undertook pneumococ-
cal vaccination [21].
Public Health System implemented in Cuba since 1959,
is based on nationwide free health service with total
access for every citizen to high quality medical assistance,
hospitalization, vaccination, social assistance and other
health services [19], and undoubtedly also has contrib-
uted to BM decreasing trends.
Infa n ts  we r e t he m ost  a ff ect ed gr o up by  BM  as  a lso
occurred in other countries [22,23]. In our study BM was
more frequent in this group between two and six months
of age, period in which they may have lost the mother
protective antibodies and still are not completely pro-
tected by vaccines. Other authors report the highest rates
of BM among infants between six and twelve months
[23,24].
In our series overall and annually male incidence
showed a significant predominance over female, coinci-
dently with other author's findings [25,26]. Some sex-spe-
cific differences in physical interaction with others and
risk behaviour, may explain these findings and will likely
require a deeper exploration.
There are a number of stages in the interaction between
a sick person and the health care system, at which man-
agement decisions may critically affect the speed with
which medical treatment is initiated. Delays in receiving
appropriate medical care to BM patients more frequently
occurs when at home, the signs of disease are not recogn-
ised. Once it has been recognised that severity of disease
requires medical attention, difficulties may be experi-
enced in consulting with the doctor (not available, low
medical attention coverage, lack of transportation,
remoteness and others). Once the doctor has seen the
patient, the signs of serious illness might not be recogn-
ised (lack of familiarity with the condition, inexperience)
[27-29] and therefore a delay in hospitalization and spe-
cific treatment may occur.
Fatal outcome depends on many factors but care-seek-
ing behaviour in the population, referral practices to hos-
Figure 1 Average annual incidence and case-fatality rate by age groups. Cuba. 1998-2007.Pérez et al. BMC Infectious Diseases 2010, 10:130
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pitals, timely and adequate medical care and specific
treatment, the underlying conditions on the patient and
the virulence of the strains are the most important [30-
34].
NPCPNIS in Cuba recommend the prompt initiation of
antibiotic therapy in intensive care unit conditions for all
confirmed cases of BM [16]. Regardless of known rela-
tionship between increase of mortality and delay in medi-
cal attention and hospitalization, that association was not
Table 2: Annual case-fatality rate of bacterial meningitis, Cuba, 1998-2007
Age 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007
<1 11.5 11.0 18.3 17.9 17.9 30.8 14.5 15.9 15.8 25.0
1-5 8.6 8.5 13.4 16.9 11.4 13.0 15.4 20.3 7.9 7.7
6-11 7.7 11.1 15.0 5.9 6.3 13.6 12.0 2.0 7.4 5.9
12-14 9.1 6.7 10.5 21.1 0.0 4.5 0.0 0.0 13.3 6.3
15-19 11.5 6.1 14.3 8.3 21.4 6.3 8.7 19.4 11.5 9.5
20-24 4.3 0.0 0.0 7.7 13.3 7.7 0.0 4.2 9.1 9.1
25-29 8.7 31.0 100.0 0.0 45.5 0.0 26.7 7.7 0.0 0.0
30-34 15.0 25.0 1.2 30.0 13.3 36.4 17.4 13.6 5.9 0.0
35-39 13.0 23.8 2.1 18.8 33.3 21.4 18.8 20.0 22.2 13.0
40-44 18.8 31.6 2.0 0.0 23.8 20.8 30.6 20.0 33.3 30.8
45-49 50.0 19.0 4.0 17.4 28.6 33.3 25.0 15.8 31.3 18.8
50-54 25.0 57.7 4.7 30.4 30.8 31.6 36.0 8.7 28.0 5.9
55-59 41.4 37.0 3.0 35.7 36.8 31.3 58.8 25.0 28.6 44.4
60-64 28.6 26.7 42.9 36.4 37.5 38.9 50.0 39.3 41.7 46.7
65-74 63.8 46.9 40.4 48.8 60.6 50.0 54.8 55.9 70.8 42.1
75-84 77.4 63.2 76.9 69.2 63.0 68.0 60.0 50.0 64.0 44.44
> 84 77.8 63.6 76.5 58.8 75.0 100.0 0.0 0.0 71.4 33.3
Total 21.7 22.3 25.7 25.9 28.5 26.5 26.6 20.4 26.3 19.2
Figure 2 Bacterial meningitis geographical distribution of the average incidence by provinces. Cuba. 1998-2007.Pérez et al. BMC Infectious Diseases 2010, 10:130
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found in our study, showing that timely medical advice
and care was received by the majority of patients.
In our study, CFR in infants (17.0%) was coincident to
those reported by authors [22,35-37], but high numbers
observed, especially among adults [38,39] and older
adults [40,41], was probable due to other factors includ-
ing poor and untimely recognition of symptoms in the
elderly.
It was observed association of the fatal outcome with
some societal groups (housewife, pensioned, imprisoned,
unemployed), as well as the infection caused by S. peumo-
niae and other identified bacteria. These societal groups
might be often more vulnerable due to socioeconomic
factors and underlying conditions. Also, poor living con-
ditions at home and gathering places as well as the infec-
tion by high virulence strains as Streptococcus  and
Staphylococcus ssp.might contribute to increase this asso-
ciation. It is important to remark that recently have been
reported cases of adrenal haemorrhage as a result of
streptococcal infection, evidencing the virulence of this
agent [42]. Furthers studies must be undertaken to evalu-
ate more precisely this factors and interactions.
Is interesting how the highest incidence of BM in Cuba
is mainly clustered in the central provinces. The Cuban
island is long and narrow, and the central region has
higher solar radiation and more climate variability than
other regions. The combined physical-geographic char-
acteristics and socioeconomic conditions may explain
this high incidence [43] and should be more precisely
assessed in future studies.
Two well-defined seasons are recognised in Cuba: the
rainy or summer (May to October) and the dry or winter
(November to April). Since 1990s, climate conditions in
winter seasons were projected to be warmer and rainier,
and rainy season were projected to be drier and hotter,
then this climate conditions are associated with increase
of respiratory communicable diseases [43].
Main causative pathogens of BM have each one a pecu-
liar seasonal pattern according to regions of the world. In
a study in Lazio, Italy [22], main peaks were observed in
January and March, coincident with our results. Seasonal
increases of BM observed in our study might be related
with seasonal distribution of the main causative patho-
gens.
Table 3: Univariate analysis of bacterial meningitis cases for delayed medical consultation and hospital admission with 
fatal outcome, Cuba, 1998-2007.
Deceased RR Confidence Interval P-value
Yes No
1.20 1.07-1.35 0.0016
Delayed medical consultation Yes 318 821
No 687 2274
Deceased RR Confidence Interval P-value
Yes No
0.98 0.87-1.11 0.7407
Delayed hospitalization Yes 264 839
No 715 221
Table 4: Associated factors with the bacterial meningitis mortality.
Variables Deceased Survivor Odds ratio 95% Confidence Interval P-value
Pensioned 271 222 6.75 5.50-8.28 0.0000
Imprisoned 7 10 4.04 1.51-10.79 0.0052
Housewife 309 434 4.03 3.38-4.81 0.0000
Unemployed 76 114 3.66 2.69-4.99 0.0000
Other identified bacteria 109 223 2.01 1.55 - 2.61 0.0000
S. pneumoniae 389 742 1.87 1.59 - 2.20 0.0000
Logistic regression analysis, Cuba 1998-2007Pérez et al. BMC Infectious Diseases 2010, 10:130
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Conclusions
A decade of BM surveillance in Cuba evidenced a reduc-
tion in the incidence after using effective preventive and
control measures (health education, high coverage vacci-
nation against meningococcus B and C, and Hib, timely
hotbed control and others), but still vital efforts are
required to decrease CFR, especially in the elderly and
other societal groups included in the study.
Future vaccination against S. pneumoniae in high risk
population will decrease even more the incidence of these
lethal infections.
Continuous monitoring of BM and further studies will
make possible to assess the need for putting new strate-
gies for the control of these severe groups of diseases in
the benefit of the population.
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